57 related articles for article (PubMed ID: 33863300)
1. The Effectiveness of 23-valent Pneumococcal Polysaccharide Vaccine on Elderly Colorectal Cancer Long-Term Survivors: A population-based exact-matched cohort study.
Lee MS; Chiou SY; Hsu FC; Lin HY; Li CY; Hung SK; Yu BH; Wu CC; Chen LC; Chew CH; Chiou WY
Hum Vaccin Immunother; 2024 Dec; 20(1):2350093. PubMed ID: 38744302
[TBL] [Abstract][Full Text] [Related]
2. Prior pneumococcal vaccination improves in-hospital mortality among elderly population hospitalized due to community-acquired pneumonia.
Kim S; Kim MJ; Myong JP; Lee YH; Kim BY; Hwang A; Kim GO; Jeong SH; Yoon HK; An TJ; Lim JU
BMC Pulm Med; 2024 Apr; 24(1):168. PubMed ID: 38589839
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.
Maruyama T; Taguchi O; Niederman MS; Morser J; Kobayashi H; Kobayashi T; D'Alessandro-Gabazza C; Nakayama S; Nishikubo K; Noguchi T; Takei Y; Gabazza EC
BMJ; 2010 Mar; 340():c1004. PubMed ID: 20211953
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal vaccine and patients with pulmonary diseases.
Mirsaeidi M; Ebrahimi G; Allen MB; Aliberti S
Am J Med; 2014 Sep; 127(9):886.e1-8. PubMed ID: 24852934
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficient management of diabetic foot ulcer using simultaneous foot ulcer closure and surgical off-loading.
Terabe Y; Kaneko N; Nakabayashi K; Matsui A; Ando H
JPRAS Open; 2021 Dec; 30():1-5. PubMed ID: 34307819
[TBL] [Abstract][Full Text] [Related]
6. Review of Vaccination Recommendations in Guidelines for Non-Communicable Diseases with Highest Global Disease Burden among Adults 75 Years Old and Above.
Ishak AR; Hsieh YC; Srinivasan H; See KC
Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376465
[TBL] [Abstract][Full Text] [Related]
7. The remarkable history of pneumococcal vaccination: an ongoing challenge.
Musher DM; Anderson R; Feldman C
Pneumonia (Nathan); 2022 Sep; 14(1):5. PubMed ID: 36153636
[TBL] [Abstract][Full Text] [Related]
8. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type
Chandler T; Furmanek S; Carrico R; Balcom D; Arnold F; Ramirez J
Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336135
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.
Niederman MS; Folaranmi T; Buchwald UK; Musey L; Cripps AW; Johnson KD
Expert Rev Vaccines; 2021 Mar; 20(3):243-256. PubMed ID: 33478306
[No Abstract] [Full Text] [Related]
10. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal pneumonia in the elderly with chronic respiratory diseases: a case-control study of a single center.
Masuda T; Nakatani E; Shirai T; Akamatsu T; Tamura K; Takahashi S; Tanaka Y; Watanabe H; Endo Y; Suzuki T; Saigusa M; Yamamoto A; Morita S; Sato Y; Asada K
BMC Pulm Med; 2021 Apr; 21(1):123. PubMed ID: 33863300
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016.
Vila-Corcoles A; Hospital I; Ochoa-Gondar O; Satue E; de Diego C; Vila-Rovira A; Gómez-Bertomeu F; Raga X; Aragón M
Vaccine; 2020 Jan; 38(5):1170-1180. PubMed ID: 31759735
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.
Leventer-Roberts M; Feldman BS; Brufman I; Cohen-Stavi CJ; Hoshen M; Balicer RD
Clin Infect Dis; 2015 May; 60(10):1472-80. PubMed ID: 25669354
[TBL] [Abstract][Full Text] [Related]
15. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.
Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y
Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
